Simer Bains presented data from an observational study revealing that patients with colorectal cancer that have been treated with aspirin live significantly longer than patients that did not use aspirin. The data in this study came from the Norwegian Cancer Registry and the Norwegian Prescription Database and included all patients diagnosed with colorectal cancer in Norway in the period 2004-2011.
Professor David Kerr, University of Oxford, commented on the aspirin registry study presented at ASCO, 2015 in a view-article in Medscape published on 22 May.
Furthermore, a new multicenter study has recently been initiated focusing on aspirin effects on patients suffering from colorectal cancer that have also surgically removed liver metastases. This study is a collaboration with Oslo University Hopsital (Bjørn Atle Bjørnbeth) as well as with colleagues in Stavanger, Bergen, Trondheim and Tromsø.